C69.50 — Malignant neoplasm of unspecified lacrimal gland and duct
C69.50 is a billable, specific ICD-10-CM code for malignant neoplasm of unspecified lacrimal gland and duct. It is valid for submission on a claim.
Risk adjustment
C69.50 risk-adjusts. Under the CMS-HCC V28 model it maps to this category:
- HCC 23 Prostate, Breast, and Other Cancers and Tumors0.186 RAF
Coefficient shown for the Community Non-dual Aged segment. A higher HCC in the same hierarchy will suppress this one, so capturing it does not always add score.
Medicare coverage
C69.50 is named in 31 Medicare coverage policies — 31 listing it as supporting medical necessity. Which of them applies to you depends on your Medicare contractor, and coverage genuinely differs by state.
- A55717Billing and Coding: Lab: Flow Cytometry
- A56748Billing and Coding: White Cell Colony Stimulating Factors
- A56827Billing and Coding: Proton Beam Therapy
- A56867Billing and Coding: Genomic Sequence Analysis Panels in the Treatment of Solid Organ Neoplasms
Code history
C69.50 has not changed since FY2024 — no addition, revision or deletion across the three most recent ICD-10-CM releases.
Related codes at this level
Codes that share C69.5. If C69.50 is not quite right, the correct code is usually one of these.
Questions about C69.50
- Is C69.50 a billable ICD-10-CM code?
- Yes. C69.50 is a billable, specific ICD-10-CM code and is valid for submission on a claim.
- Where does C69.50 sit in the tabular list?
- Neoplasms (C00-D49), in the block Malignant neoplasms of eye, brain and other parts of central nervous system (C69-C72).